Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petitti, D. B.
Right arrow Articles by Bernstein, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petitti, D. B.
Right arrow Articles by Bernstein, A.

(Stroke. 1998;29:23-28.)
© 1998 American Heart Association, Inc.


Original Contributions

Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement Therapy

Diana B. Petitti, MD; Stephen Sidney, MD; Charles P. Quesenberry, Jr, PhD; Allan Bernstein, MD

From the Kaiser Permanente Medical Care Program, Southern California (D.B.P.) and Northern California (S.S., C.P.Q., A.B.).

Background and Purpose—Information about the risk of stroke in current postmenopausal hormone users is limited.

Methods—In this case-control study, women aged 45 to 74 years hospitalized with a fatal or nonfatal stroke in any of 10 Northern California Kaiser Permanente facilities during the period November 1991 to November 1994 were identified as cases. Controls were selected at random from female Health Plan members. Data regarding use of estrogen plus progestogen or estrogen alone were obtained in interviews.

Results—The analysis was based on nonproxy responses from 349 cases of ischemic stroke and 349 matched control subjects. After adjustment for confounders, the odds ratio for ischemic stroke in current hormone users was 1.03 (95% confidence interval, 0.65 to 1.65). The odds ratios for ischemic stroke in current hormone users showed no clear trend of increasing or decreasing risk in relation to duration of hormone use. The odds ratio for ischemic stroke in past hormone users was 0.84 (95% confidence interval, 0.54 to 1.32).

Conclusions—In this study postmenopausal hormone use was not associated with an increase or decrease in the risk of ischemic stroke, a finding that is consistent with the body of literature on this topic.


Key Words: cerebral infarction • cerebrovascular disorders • hemorrhagic stroke • stroke, ischemic




This article has been cited by other articles:


Home page
NeurologyHome page
M. A. de Lecinana, J. A. Egido, C. Fernandez, E. Martinez-Vila, S. Santos, A. Morales, E. Martinez, A. Pareja, J. Alvarez-Sabin, I. Casado, et al.
Risk of ischemic stroke and lifetime estrogen exposure
Neurology, January 2, 2007; 68(1): 33 - 38.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. D. Bushnell, P. Hurn, C. Colton, V. M. Miller, G. del Zoppo, M. S.V. Elkind, B. Stern, D. Herrington, G. Ford-Lynch, P. Gorelick, et al.
Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group
Stroke, September 1, 2006; 37(9): 2387 - 2399.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. B. Dubal, S. W. Rau, P. J. Shughrue, H. Zhu, J. Yu, A. B. Cashion, S. Suzuki, L. M. Gerhold, M. B. Bottner, S. B. Dubal, et al.
Differential Modulation of Estrogen Receptors (ERs) in Ischemic Brain Injury: A Role for ER{alpha} in Estradiol-Mediated Protection against Delayed Cell Death
Endocrinology, June 1, 2006; 147(6): 3076 - 3084.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. L. Prentice, R. Langer, M. L. Stefanick, B. V. Howard, M. Pettinger, G. Anderson, D. Barad, J. D. Curb, J. Kotchen, L. Kuller, et al.
Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial
Am. J. Epidemiol., September 1, 2005; 162(5): 404 - 414.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Wassertheil-Smoller, S. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, A. Baird, T. Kotchen, J. D. Curb, H. Black, J. E. Rossouw, et al.
Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women: The Women's Health Initiative: A Randomized Trial
JAMA, May 28, 2003; 289(20): 2673 - 2684.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. B. Clarkson, M. S. Anthony, T. S. Mikkola, and R. W. St Clair
Comparison of Tibolone and Conjugated Equine Estrogens Effects on Carotid Artery Atherosclerosis of Postmenopausal Monkeys
Stroke, November 1, 2002; 33(11): 2700 - 2703.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. N. Lemaitre, S. R. Heckbert, B. M. Psaty, N. L. Smith, R. C. Kaplan, and W. T. Longstreth Jr
Hormone Replacement Therapy and Associated Risk of Stroke in Postmenopausal Women
Arch Intern Med, September 23, 2002; 162(17): 1954 - 1960.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan
Postmenopausal Hormone Replacement Therapy: Scientific Review
JAMA, August 21, 2002; 288(7): 872 - 881.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. M. Viscoli, L. M. Brass, W. N. Kernan, P. M. Sarrel, S. Suissa, and R. I. Horwitz
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
N. Engl. J. Med., October 25, 2001; 345(17): 1243 - 1249.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. D. Bushnell, G. P. Samsa, and L. B. Goldstein
Hormone replacement therapy and ischemic stroke severity in women: A case-control study
Neurology, May 22, 2001; 56(10): 1304 - 1307.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Simon, J. Hsia, J. A. Cauley, C. Richards, F. Harris, J. Fong, E. Barrett-Connor, and S. B. Hulley
Postmenopausal Hormone Therapy and Risk of Stroke : The Heart and Estrogen-progestin Replacement Study (HERS)
Circulation, February 6, 2001; 103(5): 638 - 642.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al.
Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Circulation, January 2, 2001; 103(1): 163 - 182.
[Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al.
Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association
Stroke, January 1, 2001; 32(1): 280 - 299.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
F. Grodstein, J. E. Manson, G. A. Colditz, W. C. Willett, F. E. Speizer, and M. J. Stampfer
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease
Ann Intern Med, December 19, 2000; 133(12): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. I. Rossberg, S. J. Murphy, R. J. Traystman, P. D. Hurn, and H. A. Kontos
LY353381.HCl, a Selective Estrogen Receptor Modulator, and Experimental Stroke Editorial Comment
Stroke, December 1, 2000; 31(12): 3041 - 3046.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. G. Geary, D. N. Krause, and S. P. Duckles
Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H511 - H519.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Sarti, D. Rastenyte, Z. Cepaitis, and J. Tuomilehto
International Trends in Mortality From Stroke, 1968 to 1994
Stroke, July 1, 2000; 31(7): 1588 - 1601.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Sampei, S. Goto, N. J. Alkayed, B. J. Crain, K. S. Korach, R. J. Traystman, G. E. Demas, R. J. Nelson, P. D. Hurn, and S. Piper Duckles
Stroke in Estrogen Receptor-{alpha}-Deficient Mice • Editorial Comment
Stroke, March 1, 2000; 31(3): 738 - 744.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. J. Alkayed, S. J. Murphy, R. J. Traystman, P. D. Hurn, and V. M. Miller
Neuroprotective Effects of Female Gonadal Steroids in Reproductively Senescent Female Rats Editorial Comment
Stroke, January 1, 2000; 31(1): 161 - 168.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Rusa, N. J. Alkayed, B. J. Crain, R. J. Traystman, A. S. Kimes, E. D. London, J. A. Klaus, P. D. Hurn, and C. Iadecola
17{beta}-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female Animals • Editorial Comment
Stroke, August 1, 1999; 30(8): 1665 - 1670.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. G. Hart, L. A. Pearce, R. McBride, R. M. Rothbart, and R. W. Asinger
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation : Analysis of 2012 Participants in the SPAF I–III Clinical Trials
Stroke, June 1, 1999; 30(6): 1223 - 1229.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. X. Pan, J. Boal, for the Geriatrics Journal Club, E. Banks, V. Beral, P. J. L. Ong, M. B. Sorensen, C. S. Hayward, C. M. Webb, P. Collins, et al.
Hormone Replacement Therapy for Secondary Prevention of Coronary Heart Disease
JAMA, March 3, 1999; 281(9): 794 - 797.
[Full Text] [PDF]


Home page
CirculationHome page
M.-G. Bousser
Stroke in Women : The 1997 Paul Dudley White International Lecture
Circulation, February 2, 1999; 99(4): 463 - 467.
[Full Text] [PDF]


Home page
StrokeHome page
A. Kastrup, J. Dichgans, M. Niemeier, and M. Schabet
Changes of Cerebrovascular CO2 Reactivity During Normal Aging
Stroke, July 1, 1998; 29(7): 1311 - 1314.
[Abstract] [Full Text] [PDF]